Motohiro Tamiya - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Motohiro Tamiya

Showing results (191-200 of 192) with videos related to

Pageof 20

Sort By:

You have reached the last page of results.This site can display upto 192 results.

Science Advances|May 19, 2023

Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8<sup>+</sup> T cell cytotoxicity and proliferationYujiro Naito, Shohei Koyama, Kentaro Masuhiro, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2024

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 StudyNatasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, et al.

Pageof 20

Search research articles

Showing results (191-200 of 192) with videos related to

Sort By:

Pageof 20

You have reached the last page of results.This site can display upto 192 results.

Science Advances|May 19, 2023

Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8<sup>+</sup> T cell cytotoxicity and proliferationYujiro Naito, Shohei Koyama, Kentaro Masuhiro, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2024

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 StudyNatasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, et al.

Pageof 20